Eli Lilly Aktie

Eli Lilly für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 858560 / ISIN: US5324571083

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
21.08.2024 10:36:00

Eli Lilly Stock Could Soar to $1,150, According to a Wall Street Analyst. Is It a Buy at Around $945?

Shares of Eli Lilly (NYSE: LLY) have already soared by about 58% in 2024. Despite the run-up, many analysts on Wall Street think the pharmaceutical stock can climb a lot higher. Bank of America analyst Geoff Meacham is so encouraged by the company's recent progress with obesity, diabetes, and Alzheimer's disease that he thinks the stock can climb to $1,150 per share.Meacham's recently updated price target implies a gain of 25% from the stock's closing price on Aug. 19, but that gain is a long way from guaranteed. Let's weigh the risks this stock presents against the opportunities in front of its pharmaceutical business to see if it presents an acceptable risk-to-reward ratio for everyday investors.Eli Lilly sells a handful of different blockbuster drugs, but all attention right now is on its new best-seller tirzepatide. This is the generic name of the treatment it markets as Mounjaro for diabetes and Zepbound for weight management. Mounjaro earned approval from the U.S. Food and Drug Administration (FDA) in 2022, and Zepbound followed in November 2023.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu Eli Lillymehr Analysen

20.12.24 Eli Lilly Buy Jefferies & Company Inc.
31.10.24 Eli Lilly Buy Jefferies & Company Inc.
13.02.24 Eli Lilly Buy Jefferies & Company Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Eli Lilly 744,10 -0,55% Eli Lilly